Thuja Capital B.V.

About The Fund

Thuja Capital B.V. is a venture capital firm based in Utrecht, Netherlands, with a focus on investing in the healthcare sector. They specifically target the Biotech, Medical Devices (& Hospital Services), and Life Sciences industries. With an equity expertise, the firm positions itself as a key player in supporting startups and early-stage companies. Thuja Capital manages assets worth €50 million and operates out of the LSI Building at Yalelaan 62 in Utrecht. They adopt a hands-on investment approach that is centered around the building of healthcare ventures with lasting impact for both patients and society. They seek to invest in healthcare innovation ranging from startup to scale-up stages. Thuja Capital values daring entrepreneurs and is always on the lookout for paradigm-shifting ideas that have the potential to make a significant impact in healthcare. Their investment strategy includes tranched investments, which allows them to balance risk and return effectively. The firm's commitment to sustainability and ethical investing is reflected in their emphasis on Impact & ESG (Environmental, Social, and Governance) where they support the development of novel therapies in areas of high unmet medical need. Thuja Capital is actively involved in the EU Life Sciences community and contributes to the ESG Knowledge Project. Their portfolio showcases a range of active investments in promising healthcare ventures, demonstrating their dedication to nurturing innovations from the ground up. Partnerships and an experienced team with advisory board members play a crucial role in their successful investment management. Thuja Capital's approach is rooted in the Benelux but their services expand across Europe. The firm regularly engages in community-building and thought leadership within the healthcare investment sector, as evidenced by their participation in news media and events.